Eric Dobmeier
Sr. VP, Corporate Development, Seagen.
Companies
- Jade Biosciences, Inc.Board member May 1, 2025 to now1
- Janux Therapeutics, Inc.Board member Jul 22, 2024 to now2
- Structure Therapeutics Inc.Board member Feb 2, 2023 to now3
- Atara Biotherapeutics, Inc.Board member Mar 30, 2015 to Nov 14, 20234
- CHINOOK THERAPEUTICS, INC.Board member Oct 7, 2020 to Aug 11, 20235
- CHINOOK THERAPEUTICS, INC.Chief executive officer Oct 7, 2020 to Aug 11, 20235
- CHINOOK THERAPEUTICS, INC.President Oct 7, 2020 to Aug 11, 20235
- Adaptive BiotechnologiesBoard member Jun 26, 2019 to Feb 17, 20216
- Aravive, Inc.Board member Jun 6, 2017 to Dec 22, 20177
- SeagenChief operating officer Jun 21, 2011 to Dec 6, 20178
- SeagenSr. VP, Corporate Development Feb 1, 2006 to Jun 13, 20119
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atara Biotherapeutics, Inc. ATRA563,325 shares10$5.2M at $9.18Nov 10, 2023
- Janux Therapeutics, Inc. JANX15,481 shares11$268.1K at $17.32Jun 11, 2026
- CHINOOK THERAPEUTICS, INC.0 shares12Aug 11, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Granted 5,500 shares of Janux Therapeutics, Inc.11
- Jun 11, 2025Granted 3,750 shares of Janux Therapeutics, Inc.13
- Jul 19, 2024Granted 2,500 shares of Janux Therapeutics, Inc.14
- Jul 19, 2024Granted 1,231 shares of Janux Therapeutics, Inc.15
- Jul 19, 2024Granted 5,000 shares of Janux Therapeutics, Inc.14
- Nov 10, 2023Bought 446,825 shares at $0.23 of Atara Biotherapeutics, Inc.10
- Aug 11, 2023Returned to company 301,138 shares of CHINOOK THERAPEUTICS, INC.12
- May 31, 2023Granted 57,000 shares of Atara Biotherapeutics, Inc.16
- Apr 24, 2023Sold 1,200 shares at $22.26 of CHINOOK THERAPEUTICS, INC.17
- Apr 24, 2023Sold 23,800 shares at $21.58 of CHINOOK THERAPEUTICS, INC.17
- Apr 24, 2023Exercised options 25,000 shares at $0.42 of CHINOOK THERAPEUTICS, INC.17
- Feb 10, 2023Sold 8,097 shares at $23.75 of CHINOOK THERAPEUTICS, INC.18
- Feb 10, 2023Exercised options 20,248 shares of CHINOOK THERAPEUTICS, INC.18
- Jan 31, 2023Sold 7,688 shares at $24.68 of CHINOOK THERAPEUTICS, INC.19
- Jan 31, 2023Exercised options 24,999 shares of CHINOOK THERAPEUTICS, INC.19
- Jan 30, 2023Sold 25,000 shares at $24.54 of CHINOOK THERAPEUTICS, INC.19
- Jan 30, 2023Exercised options 25,000 shares at $0.42 of CHINOOK THERAPEUTICS, INC.19
- Dec 14, 2022Exercised options 30,000 shares at $0.35 of CHINOOK THERAPEUTICS, INC.20
- Dec 1, 2022Sold 30,000 shares at $22.31 of CHINOOK THERAPEUTICS, INC.21
- Dec 1, 2022Exercised options 60,000 shares at $0.42 of CHINOOK THERAPEUTICS, INC.21
- Dec 1, 2022Gift 25,000 shares of CHINOOK THERAPEUTICS, INC.21
- Oct 6, 2022Exercised options 30,796 shares of CHINOOK THERAPEUTICS, INC.22
- Jun 23, 2022Granted 20,500 shares of Atara Biotherapeutics, Inc.23
- May 25, 2022Bought 5,000 shares at $13.03 of CHINOOK THERAPEUTICS, INC.24
- Feb 10, 2022Exercised options 20,247 shares of CHINOOK THERAPEUTICS, INC.25
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJade Biosciences, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARAravive, Inc., Board member
- 8SEC EDGARSeagen, Chief operating officer
- 9
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Jun 13, 2025
- 14SEC EDGARForm 4 filed Jul 22, 2024
- 15SEC EDGARForm 4 filed Jul 24, 2024
- 16SEC EDGARForm 4 filed Jun 2, 2023
- 17SEC EDGARForm 4 filed Apr 26, 2023
- 18SEC EDGARForm 4 filed Feb 15, 2023
- 19SEC EDGARForm 4 filed Feb 1, 2023
- 20SEC EDGARForm 4 filed Dec 15, 2022
- 21SEC EDGARForm 4 filed Dec 2, 2022
- 22SEC EDGARForm 4 filed Oct 11, 2022
- 23SEC EDGARForm 4 filed Jun 27, 2022
- 24SEC EDGARForm 4 filed May 27, 2022
- 25SEC EDGARForm 4 filed Feb 14, 2022